5-FLUOROURACIL IONTOPHORETIC THERAPY FOR BOWENS-DISEASE

Citation
Ml. Welch et al., 5-FLUOROURACIL IONTOPHORETIC THERAPY FOR BOWENS-DISEASE, Journal of the American Academy of Dermatology, 36(6), 1997, pp. 956-958
Citations number
12
Categorie Soggetti
Dermatology & Venereal Diseases
ISSN journal
01909622
Volume
36
Issue
6
Year of publication
1997
Part
1
Pages
956 - 958
Database
ISI
SICI code
0190-9622(1997)36:6<956:5ITFB>2.0.ZU;2-S
Abstract
Background: Topical 5-fluorouracil (5-FU) is an accepted therapy for B owen's disease, Recurrences with this method have been attributed to d eep follicular involvement and poor patient compliance because of the prolonged treatment time required. Objective: We sought to determine w hether iontophoresis of 5-FU is an effective therapy for Bowen's disea se. Methods: Twenty-six patients with biopsy-proven Bowen's disease re ceived eight 5-FU iontophoretic treatments in 4 weeks, Local excision was done 3 months after the last treat ment. The specimens were step-s ectioned and evaluated for any histologic evidence of bowenoid changes , Results: Only 1 of 26 patients showed histologic evidence of Bowen's disease 3 months after treatment, Conclusion: 5-FU iontophoresis appe ars to be a safe, effective, and well-tolerated therapy for Bowen's di sease.